216 related articles for article (PubMed ID: 36166943)
1. Puerarin: A review of its mechanisms of action and clinical studies in ophthalmology.
Meng F; Guo B; Ma YQ; Li KW; Niu FJ
Phytomedicine; 2022 Dec; 107():154465. PubMed ID: 36166943
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics of the anti-inflammatory effect of Pueraria lobata and Pueraria lobata var. Thomsonii in rats.
Xi C; Zhang M; Li B; Meng X; Xu S; Du H; Wang X; Xu J; Ke H; Cui Y; Qu F
J Ethnopharmacol; 2023 Apr; 306():116144. PubMed ID: 36649849
[TBL] [Abstract][Full Text] [Related]
3. Puerarin inhibits adhesion molecule expression in tnf-alpha-stimulated human endothelial cells via modulation of the nuclear factor kappaB pathway.
Hu W; Zhang Q; Yang X; Wang Y; Sun L
Pharmacology; 2010; 85(1):27-35. PubMed ID: 20016245
[TBL] [Abstract][Full Text] [Related]
4. Progress on the pharmacological research of puerarin: a review.
Wei SY; Chen Y; Xu XY
Chin J Nat Med; 2014 Jun; 12(6):407-14. PubMed ID: 24969520
[TBL] [Abstract][Full Text] [Related]
5. Puerarin prevents vascular endothelial injury through suppression of NF-κB activation in LPS-challenged human umbilical vein endothelial cells.
Deng HF; Wang S; Li L; Zhou Q; Guo WB; Wang XL; Liu MD; Liu K; Xiao XZ
Biomed Pharmacother; 2018 Aug; 104():261-267. PubMed ID: 29775893
[TBL] [Abstract][Full Text] [Related]
6. Protective effects and mechanism of puerarin targeting PI3K/Akt signal pathway on neurological diseases.
Wang Q; Shen ZN; Zhang SJ; Sun Y; Zheng FJ; Li YH
Front Pharmacol; 2022; 13():1022053. PubMed ID: 36353499
[TBL] [Abstract][Full Text] [Related]
7. Puerarin attenuates glucocorticoid-induced apoptosis of hFOB1.19 cells through the JNK- and Akt-mediated mitochondrial apoptotic pathways.
Yu D; Mu S; Zhao D; Wang G; Chen Z; Ren H; Fu Q
Int J Mol Med; 2015 Aug; 36(2):345-54. PubMed ID: 26101183
[TBL] [Abstract][Full Text] [Related]
8. Exploring the mechanism of the antithrombotic effects of Pueraria lobata and Pueraria lobata var. thomsonii based on network pharmacology.
Wang S; Yao W; Zhu X; Wang J; Lu L; Zhu N; Lan T; Kuang Y; Zhu W; Liu R; Huang L
J Ethnopharmacol; 2023 Jan; 300():115701. PubMed ID: 36089177
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of Anticancer Activities of Puerarin.
Ahmad B; Khan S; Liu Y; Xue M; Nabi G; Kumar S; Alshwmi M; Qarluq AW
Cancer Manag Res; 2020; 12():79-90. PubMed ID: 32021425
[TBL] [Abstract][Full Text] [Related]
10. Comparative Transcriptome Analysis of
Xi H; Zhu Y; Sun W; Tang N; Xu Z; Shang X; Zhang Y; Yan H; Li C
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671554
[No Abstract] [Full Text] [Related]
11. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
Hien TT; Kim HG; Han EH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of isoflavones and triterpenoid saponins from pueraria lobata on liver diseases: A review.
He H; Peng S; Song X; Jia R; Zou Y; Li L; Yin Z
Food Sci Nutr; 2022 Jan; 10(1):272-285. PubMed ID: 35035928
[TBL] [Abstract][Full Text] [Related]
13. New hepatoprotective isoflavone glucosides from
Sun Y; Zhang H; Cheng M; Cao S; Qiao M; Zhang B; Ding L; Qiu F
Nat Prod Res; 2019 Dec; 33(24):3485-3492. PubMed ID: 29968479
[TBL] [Abstract][Full Text] [Related]
14. Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone From Pueraria lobata.
Chen X; Yu J; Shi J
Am J Chin Med; 2018; 46(8):1771-1789. PubMed ID: 30525896
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant-Rich Extract from Plantaginis Semen Ameliorates Diabetic Retinal Injury in a Streptozotocin-Induced Diabetic Rat Model.
Tzeng TF; Liu WY; Liou SS; Hong TY; Liu IM
Nutrients; 2016 Sep; 8(9):. PubMed ID: 27649243
[TBL] [Abstract][Full Text] [Related]
16. Anti-oxidative and TNF-α suppressive activities of puerarin derivative (4AC) in RAW264.7 cells and collagen-induced arthritic rats.
Xiao C; Li J; Dong X; He X; Niu X; Liu C; Zhong G; Bauer R; Yang D; Lu A
Eur J Pharmacol; 2011 Sep; 666(1-3):242-50. PubMed ID: 21651907
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of puerarin against cerebral diseases: From bench to bedside.
Liu T; Su K; Cai W; Ao H; Li M
Eur J Pharmacol; 2023 Aug; 953():175695. PubMed ID: 36977450
[TBL] [Abstract][Full Text] [Related]
18. Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells.
Wang Y; Yang C; Xie WL; Zhao YW; Li ZM; Sun WJ; Li LZ
Phytomedicine; 2014; 21(8-9):1032-6. PubMed ID: 24854571
[TBL] [Abstract][Full Text] [Related]
19. Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation.
Wang Y; Wang WL; Xie WL; Li LZ; Sun J; Sun WJ; Gong HY
Phytomedicine; 2013 Jul; 20(10):787-96. PubMed ID: 23639192
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory effect of puerarin on bone formation through activation of PI3K/Akt pathway in rat calvaria osteoblasts.
Zhang Y; Zeng X; Zhang L; Zheng X
Planta Med; 2007 Apr; 73(4):341-7. PubMed ID: 17443435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
